Work

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Year: 2012

Type: article

Source: Gene Therapy

DOI: 10.1038/gt.2012.37

Authors: J C M van der Loo, W P Swaney, E Grassman, A Terwilliger, T Higashimoto, A Schambach, S Hacein-Bey-Abina, D L Nordling, M Cavazzana-Calvo, A J Thrasher, D A Williams, L Reeves, P Malik

Institutions: Cincinnati Children's Hospital Medical Center, Barnes-Jewish Hospital, Medizinische Hochschule Hannover, Hôpital Necker-Enfants Malades, Inserm, Institut Necker Enfants Malades, Hôpitaux Universitaires Paris-Ouest, Université Paris Descartes, Great Ormond Street Hospital, University College London, Boston Children's Hospital, Harvard University, Indiana University School of Medicine

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cincinnati Children's Hospital Medical Center, Wellcome Trust, European Commission, Deutscher Akademischer Austauschdienst, Bundesministerium für Bildung und Forschung, Medical Research Council, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: G1260873166, G2159542745, Development of novel therapeutic approaches for primary immunodeficiency.

OpenAlex ID: W2081946162

FWCI: 1.594

Cites: 27

Cited by: 14

Related to: 10